SEC Form 424B3 filed by Churchill Capital Corp X

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

8-K - Churchill Capital Corp X/Cayman (0002007825) (Filer)

Execution phase advances quantum-enabled approaches designed to improve energy grid efficiency, resilience, and operational scale Infleqtion, a global leader in quantum computing and quantum sensing, today announced it has executed its contract with the U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E), formally launching development under its $6.2 million Enhancing Neutral-atom Computers for Optimizing Delivery of Energy (ENCODE) project. This program, which includes key collaborations with Argonne National Laboratory, the National Laboratory of the Rockies (NRL), EPRI, and ComEd, is the first quantum project for the department focusing on advancing the applic

Live test between Chicago and Northwest Indiana shows up to 40X improvement over GPS for keeping digital systems synchronized Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced a successful live demonstration with Quantum Corridor showing how critical digital infrastructure can stay precisely synchronized without relying on GPS. Quantum Corridor is a quantum-safe, ultra-fast, and highly secure fiber-optic network in the Midwest enabling next-generation communication. The demonstration was conducted across 21.8 kilometers of live urban fiber between Chicago's ORD10 Data Center (350 Cermak) and the Digital Crossroad Data

Backed by Wellcome Leap program funding and selected to advance to final-stage demonstrations, Infleqtion moves forward with quantum-enabled biomarker discovery for precision oncology Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced that its quantum software team, together with collaborators at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge, a global program focused on demonstrating quantum-enabled solutions for human health. The news comes as Infleqtion prepares to go public through a merger

3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)